TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma

We show TPX2, a regulator of Aurora-A, is associated with high grade and stage of ccRCC, and is an independent predictor of recurrence. Future studies are warranted testing its role in ccRCC biology, and its potential as a therapeutic target.